Press release
Tuberculosis Drugs Market Size, Share, Industry Growth, Analysis and Forecast 2023-2029
The global tuberculosis drugs market is anticipated to grow at a significant CAGR during the forecast period. The major factor that is anticipated to augment the market during the forecast period includes an increase in R&D investments and an increase in new drug developments. For instance, a US-based TB Alliance, which is a non-profit organization, has developed a new drug for treating highly drug-resistant forms of tuberculosis. The TB Alliance received the US FDA approval in August 2019, for Pretomnid, a combination regimen with bedaquiline and linezolid, which is developed and indicated for the treatment of patients with XDR-TB, or intolerant non-responsive MDR-TB.To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/tuberculosis-drugs-market
Further, to commercialize their newly developed drugs, the market players are focusing on strategic collaborations such as partnerships and collaborations, and mergers & acquisitions. For instance, in April 2019, Mylan NV, a pharmaceuticals company, collaborated with TB Alliance to commercialize the Pretomanid drug for treating pulmonary tuberculosis (TB). The other factor that is responsible for fuelling the market growth includes a high prevalence of TB across the globe. For instance, according to the World Health Organisation's (WHO) global tuberculosis report 2018, around 10 million people globally suffered from Tuberculosis in 2017.
Tuberculosis (TB) is a chronic condition and has become a global disease burden. Manufacturers of TB drugs are focused on developing drugs that can shorten the duration of treatment, and support overcoming the challenges of drug-susceptible TB and drug-resistant TB. The treatment of TB is divided into three types, such as first-line therapy, second-line therapy, and combination therapy. Moreover, the other factor that is expected to propel the market growth includes the advent of novel therapies that are expected to improve the duration of treating TB.
Market Coverage
• The market number available for - 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally
Competitive Landscape: Johnson & Johnson Services, Inc., Lupin Ltd, Novartis International AG, Otsuka Pharmaceutical Co., Ltd, and Pfizer Inc.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Tuberculosis Drugs Market Report by Segment
By Therapy
• First-Line Therapy
• Second-Line Therapy
• Combination Therapy
By Disease Type
• Latent Tuberculosis
• Active Tuberculosis
A full report of Tuberculosis Drugs Market is available at: https://www.omrglobal.com/industry-reports/tuberculosis-drugs-market
Tuberculosis Drugs Market- Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Johnson & Johnson Services, Inc.
• Lupin Ltd
• Novartis International AG
• Otsuka Pharmaceutical Co., Ltd.
• Pfizer Inc.
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Visit More Report at
https://www.asiatimeskorea.com/press-release/%eb%85%b8%ec%b6%9c-%ec%a0%84-%ec%98%88%eb%b0%a9prep-hiv-%ec%95%bd%eb%ac%bc-%ec%8b%9c%ec%9e%a5-%ec%84%b1%ec%9e%a5-%ec%a0%90%ec%9c%a0%ec%9c%a8-%eb%8f%99%ed%96%a5-%eb%b0%8f-%ea%b0%9c%ec%9a%94-2023-20/243626/
https://www.diario-ya.com/regionales/2023-2029-%e5%b9%b4%e7%9b%90%e9%85%b8%e9%9b%b7%e6%b4%9b%e6%98%94%e8%8a%ac%e7%89%87%e5%b8%82%e5%9c%ba%e4%bb%bd%e9%a2%9d%e3%80%81%e8%b6%8b%e5%8a%bf%e3%80%81%e5%88%86%e6%9e%90%e5%92%8c%e9%a2%84%e6%b5%8b/318549/
https://sportmsr.com/%d8%a7%d9%84%d8%ad%d8%b5%d8%a9-%d8%a7%d9%84%d8%b3%d9%88%d9%82%d9%8a%d8%a9-%d9%84%d9%84%d8%b3%d9%88%d8%a7%d8%ba%d8%a7%d8%aa-%d8%a7%d9%84%d9%82%d8%a7%d8%a6%d9%85%d8%a9-%d8%b9%d9%84%d9%89-%d8%a7%d9%84/
https://monblogapple.com/2023/01/12/croissance-part-tendances-et-apercu-du-marche-des-medicaments-contre-le-lupus-erythemateux-dissemine-sle-2023-2029/
https://revistaeconomiasocial.com/2023/01/12/cuota-de-mercado-de-timopentina-tendencias-analisis-y-pronostico-2023-2029/
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tuberculosis Drugs Market Size, Share, Industry Growth, Analysis and Forecast 2023-2029 here
News-ID: 2883238 • Views: …
More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…

Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…

Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…

SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Tuberculosis
Revolutionizing the Fight Against Tuberculosis: Global Anti-Tuberculosis Therape …
The global Anti-Tuberculosis (TB) Therapeutics Market is on the cusp of a transformative era, driven by urgent medical need, groundbreaking scientific advances, and expanding public-private partnerships. With an estimated 10 million new TB cases reported worldwide in 2022 and 1.4 million deaths, tuberculosis remains a leading infectious disease killer, commanding critical attention from healthcare providers, governments, and pharmaceutical innovators alike. As the world rallies to eliminate this centuries-old scourge, the…
Latent Tuberculosis Infection Detection Market
Latent Tuberculosis Infection Detection Market worth $2.37 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research…
Tuberculosis (TB) Diagnostics Market - Detect, Diagnose, Defeat: Innovating Solu …
Newark, New Castle, USA - new report, titled Tuberculosis (TB) Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Tuberculosis (TB) Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Tuberculosis (TB) Diagnostics market. The report offers an overview of…
Conquering Tuberculosis: Exploring the Innovations in Mycobacterium Tuberculosis …
The global mycobacterium tuberculosis treatment market was valued at US$ 1.97 Bn in 2021 and is expected to increase at a CAGR of 1.2% over the forecast period 2022-2032.
Mycobacterium tuberculosis is a bacteria that causes tuberculosis (TB), which mostly affects the lungs. Tuberculosis is a major public health crisis concern; however, it can be cured and prevented. Adults are most often affected by tuberculosis during their most productive years. Over…
World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis is a disease that, every year, kills as many as COVID-19 does.
March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per…
Ocular Tuberculosis Therapeutics Market To Expand On Account Of Rising Tuberculo …
Research Nester released a report titled “Ocular Tuberculosis Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global ocular tuberculosis therapeutics market in terms of market segmentation by treatment, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Ocular tuberculosis is a type…